Background: Accurate prognostication of the trajectory of an illness provides multiple benefits in end-of-life care. Prognostic information facilitates more realistic decision making regarding ongoing treatment, fosters risk-benefit considerations of specific interventions, and contributes to appropriate utilization of health care services.
ROGNOSTICATION PLAYS an important role in end-of-life care. 1 Predictions about prognosis can aid in autonomous decision making by patients and families, allow for appropriate future planning, and facilitate appropriate use of resources at the end of life by avoidance of futile care. 2 While nine out of ten persons polled wish to die at home, one in five will die in the hospital, often after receiving the most technologically advanced care, a discrepancy that may arise from the inability to effectively prognosticate. 3 When patients were asked to rate important attributes of end-of-life care, 96% rated knowing what to expect about their physical condition as very important. 4 Effective prognostication can also be useful in research by ensuring both that patients with similar illness severity are compared and that findings predictive of long-term outcomes are correctly interpreted in randomized, controlled clinical trials. 5 When therapeutic options are still feasible, prognosis is not nearly as important as it becomes when treatment options and diagnostic knowledge are limited. 6 Yet physicians and other health care professionals are poorly trained in prognostication and feel ill-prepared to make such predictions. 5 The Hospice Medicare Benefit requires the patient's attending physician and the hospice medical director to certify that the patient admitted has a prognosis of 6 months or less if the disease runs its normal course; therefore, hospice programs have a definite need for an objective measure of prognosis in terms of length of survival. Physician establishment of prognosis is a key factor in timely hospice referral and facilitation of maximal benefit from hospice care. 7 The hospice program is held accountable for continued evaluation of the patient's prognosis and discharge of the patient if the prognosis deviates from the 6-month life expectancy.
Previous studies have found great variability in the ability to predict the hospice length of stay. Forster and Lynn asked two oncologists, an internist, an oncology nurse and a hospice social worker to predict the life expectancy of 108 inpatient hospice candidates. Predictions were found to be overly optimistic by an average of 3.4 weeks, the predictions were only moderately correlated with actual life-span, and no two prognosticator's predictions correlated closely with one another. 8 Christakis and Escarce analyzed the survival of 6451 hospice patients and found short survival overall (36 days), substantial variation in length of survival after enrollment, and substantial variation based on diagnosis. 9 Another study by Christakis and Lamont asked 343 different doctors to make survival estimates for 468 terminally ill patients at the time of hospice referral. Only 20% of their predictions were accurate. Sixty-three percent were overoptimistic, while 17% were overpessimistic. 10 While optimism may have value in patient care, optimistic bias in predicting length of life may often deprive patients of timely access to the full range of hospice services 7 and to personal closure, such as saying good-bye to loved ones.
A number of studies have evaluated the use of the Karnofsky Performance Scale (KPS) as a predictor of length of survival. Developed in 1948 to evaluate patient response in cancer treatment, the Karnofsky Scale evaluates functional status with a focus on the need for hospitalization. 11 Studies conflict regarding the tool's ability to predict survival, with some studies showing strong correlations and others weaker relationships with survival. 8, 12, 13 Numerous researchers have found that symptom factors are important adjuncts to the KPS in predicting length of survival. [14] [15] [16] [17] Influential symptoms include weight loss, dyspnea, dry mouth, and disorientation. 7 Bruera and colleagues found dysphagia, cognitive failure, and weight loss to be strongly associated with survival after hospice referral. 17 In a review of the literature on estimating length of survival in endstage cancer, den Daas found that performance status was the strongest variable associated with length of stay and that some aspect of problematic nutrition was the second strongest. Several studies also found that mental status deterioration was associated with a shorter length of stay. 18 In 1996, the PPS, a tool developed by the Victoria Hospice Society, Victoria, British Columbia, Canada, was introduced. 11 Designed to measure functional performance and progressive decline in palliative care patients, this tool was not oriented to evaluation for hospitalization like the Karnofsky Scale. Used in Victoria for the communication of patient status and the evaluation of home nursing care workloads, the PPS was also recommended for studying the effects of treatment on the patient, planning visits according to patient acuity, and making discharge decisions. Noted advantages of the tool are simplicity (written instructions and definitions accompanying the tool circumvent the need for any additional training) and speed (the tool can be completed within minutes).
The strength of the PPS as a prognostic guide is that it evaluates the patient's performance status (ambulation, activity, extent of the disease, and self-care) similar to the KPS, but also adds evaluation of intake and level of consciousness. The PPS should be an improvement over the KPS as a predictor of hospice length of stay as it includes three additional highly predictive variables of survival: performance status, nutritional limitations, and mental status deterioration.
Virik and Glare found the PPS to be valid and reliable in that the score on admission predicted outcome and time to death on discharge and the prediction appeared to be irrespective of other clinical or demographic variables. 19 Morita et al. found the PPS to be highly correlated with the KPS. 20 A limiting factor in using either the KPS or the PPS is that both are primarily based on the patient's functional status. For patients with aggressive disease who are not yet experiencing a decline in functionality, the score on either scale might not be reflective of the anticipated or actual prognosis.
The purposes of our study were to determine the effectiveness of the PPS as a tool for projecting the length of survival and consideration for discharge in a home-based hospice program and to compare the tool with other possible predictive variables, such as age, diagnosis, and presence of comorbidities. Although the involved hospice had utilized the tool to evaluate and document admission, ongoing appropriateness, and discharge consideration for over 5 years, no study had been done to verify its appropriateness for such use. Our intention was not to create or apply a prediction rule, but rather to evaluate the use of the PPS in a noncontrolled home-based hospice setting.
METHODS

Study sample
This study was a retrospective chart audit of 502 patients admitted to a freestanding, nonprofit home hospice program between January and March of 2001. This hospice is the only hospice serving a large metropolitan area and seven surrounding rural counties. Approximately 85% of patients served by this hospice in 2002 resided in the urban area, while 15% were from rural counties. Hospice care is provided in the patients' homes, in nursing homes, and in two units (22 beds total) operated by the hospice and located within two area hospitals.
Included in the study were those 396 patients who had a length of stay equal to or greater than 5 days; patients with shorter lengths of stay (n ϭ 106) were eliminated as many of these were seen only for assessment and did not always have a second PPS score or other supporting documentation. The fact that 21% of patients admitted to this program lived 5 days or less is reflective of overall late referral patterns in the community in which this hospice was located.
Prior to all data collection, the study received approval from both the University of Louisville Human Subjects Committee and the hospice's Research Committee.
Variables collected for this analysis included PPS ratings, comorbidities, terminal hospice diagnosis, age, gender, marital status, race, site of care and site of death, reason for discharge if discharged alive, and length of stay in days.
Admission PPS
At this hospice, the PPS was used by the admission nurse to evaluate patients at admission, by the primary nurse to evaluate the patient at each nursing visit or during each shift on the hospice inpatient unit, and by the patient care team when evaluating patients for continuing hospice care or discharge. For the purpose of this study, the PPS scores recorded at admission, upon the first nursing visit after admission, upon the last nursing prior to death, and upon review for discharge were collected.
Certain PPS scores as documented in the hospice record were adjusted during data collection. Although PPS scores are intended to be in 10% increments only, 21 some of the documented ratings were "half-fits" (as described by the Victoria Hospice Society). In these cases, scores were rounded up to the next 10% level.
Comorbidities
During data collection, each patient's admission assessment was reviewed and significant comorbidities determined and categorized using the set of comorbidity measures developed for use with administrative data by Elixhauser et al. 22 Comorbidities listed in the patient record were documented at the discretion of the admitting nurse, as the hospice used no formal listing or checklist for comorbidity documentation. A maximum of two comorbidities were entered in the database for each patient. Patients were given a comorbidity rating of 1, 2, or 3 corresponding to no comorbidities (n ϭ 58), one comorbidity (n ϭ 142), or two or more comorbidities (n ϭ 195), respectively.
Major diagnosis groups
Patient's admitting diagnosis was recorded and categorized as follows: cancer, dementia or debility, lung disease, heart disease, liver disease, renal failure, neurological disease, or other. For the purpose of our study, patients with a primary diagnosis of liver disease, renal failure, or neurological disease upon admission were combined with the "all other" diagnoses category, as there were small numbers in the individual groupings. Thus, the diagnoses of primary interest were cancer, dementia or debility, lung disease, and heart disease.
Statistical methods
Both parametric and nonparametric tests were employed based on the distribution of the variable being analyzed. Assumptions of normality and the distribution of continuous variables were investigated. The Cochran-Mantel-Haenszel chisquare test, Mann-Whitney test, and log-rank tests were used in data analyses (the test used for each analysis is given in the Results section).
For analyses involving comparisons across admission PPS score category, subject admission PPS scores were reviewed. Upon review of these scores, it was determined that the numbers of subjects in PPS score categories of 10% (n ϭ 4) and 70% (n ϭ 2) were not large enough to substantiate evaluation as individual categories. Therefore, subjects in these score categories were combined with their adjacent score categories to create two new categories: 10% to 20% and 60% to 70%.
The mortality status was determined for each patient. Patients were identified as either having died during their tenure in hospice or having been discharged alive. The Cox proportional hazards model was used to predict the time of death, using PPS score category, comorbidity status, diagnosis, age, gender, race, and marital status as independent variables. Survival times were estimated using the Kaplan-Meier method. For all statistical tests, the Type I error probability less than or equal to 0.05 was considered significant. All analyses were conducted using SAS version 8.2.
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RESULTS
The study sample included 396 of the 502 patients admitted to a home hospice program. Patient characteristics are shown in Table 1 . Patients were nearly evenly divided with regard to gender, while the majority of the patients were Caucasian. The primary diagnosis associated with admission to hospice care was that of cancer. The majority of patients received care at home.
The mean admission PPS score for patients who died in the program was 38.6% (SD ϭ 10.3), with a median admission PPS score of 40. For patients discharged alive, the mean PPS at admission was 41.2% (SD ϭ 10.4), with the median score being 40%. Overall, nearly three-quarters (74%) of all patients admitted had an admission PPS score of 40% or less. No significant difference in admission PPS score was observed between patients discharged alive versus those who died (p ϭ .117, Mann-Whitney test).
The Cox Proportional Hazards model, with admission PPS score category, comorbidity status, diagnosis, age, gender, race, and marital status as independent variables, was fit to the data. Admission PPS score and diagnosis group were the two variables found to be significantly associated (p Ͻ .05) with survival in this patient group (see Table 2 ).
The Kaplan-Meier method was employed to estimate survival (see Fig. 1 ). Survival was measured as the time from enrollment to death or discharge. The overall median length of survival after hospice enrollment was 28 days; the average was 54.4 (SD ϭ 71.8). A small percentage of patients were discharged from hospice alive (n ϭ 42; 10.6%). Analysis of survival status based on admission PPS revealed that 100% of those with scores of 10% to 20%, 96.4% of those with scores of 30%, 97.3% of those with scores of 40%, 87.9% of those with scores of 50%, and 83.3% of those with scores of 60% to 70% survived less than 6 months. In our study, hospice stays of over 6 A statistically significant difference in survival was observed between diagnosis groups (p ϭ .010, log-rank test). Pairwise log-rank tests revealed significantly longer survival for debility or dementia and lung disease patient groups in comparison to the cancer group (p ϭ.003, p ϭ .008, respectively; log-rank test). Similarly, differences in survival were observed between admission PPS score categories (see Fig. 2 ). Patients in the 30% to 40% categories survived significantly longer than those in the 10% to 20% category (p Ͻ .0001; log-rank test). Patients with admission PPS scores of 50% and greater survived significantly longer than those in each of the other categories (p Ͻ .001; log-rank test). Considering patient diagnosis by discharge status (see Table 1 ), 66% of patients who were admitted to hospice were diagnosed with cancer, but only 36% of the patients discharged alive had cancer. Although dementia or debility patients comprised 13% of the total patients admitted to this hospice, they consisted of one-third (33.3%) of all patients discharged alive. Median survival times are summarized by diagnosis and PPS category in Table 3 . Table 4 summarizes the distribution of admission PPS scores across diagnosis groups. A significant association between diagnosis and admission PPS score was observed (p ϭ .001; Cochran-Mantel-Haenszel test with modified ridit scores). Cancer and lung disease patients had larger proportions of patients with admission PPS scores in the 40% and 50% categories than did the remaining diagnosis groups.
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At this particular hospice, the lack of change in PPS from admission to time of reevaluation was used in supporting decisions to discharge a patient. Approximately 11% of the patients in this study were discharged alive from the hospice. Patients discharged alive had a mean length of stay in hospice of 114.9 (SD ϭ 95.0) days with a mean PPS score at discharge of 42.0 (SD ϭ 9.7). With a median change of 0.00 in this group of patients, no significant difference between admission PPS scores and scores at discharge was observed (p ϭ .862; Wilcoxon signed-rank test). In contrast, for patients who died while in hospice care, the median difference between admission PPS score and final PPS score was Ϫ20.0 (p Ͻ .0001; Wilcoxon signed-rank test).
DISCUSSION
Our findings related to the ability of the PPS to discriminate length of survival in a real-life community hospice setting mirror those of Morita et al. 20 who found certain of the scores not to have prominent differentiation. They found this lack of differentiation to be between the 10% and 20% categories, among the 30%, 40%, and 50% categories, and between the 60% and Ն70% categories, while we found a lack of differentiation in length of survival between the 30% and 40% categories and between the 50% and 60% to 70% cat-
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Proportion Surviving
Length of Survival (days) Referring to the PPS table (see Appendix 1), criteria for categorization of patients, scores of 30% and 40% are differentiated according to ambulation (totally bed bound at 30% versus mainly in bed at 40%), activity and evidence of disease (unable to do any activity at 30% and unable to do most activity at 40%), and self-care (total care at 30%, mainly assistance at 40%). If a clinician were to refer only to the table, discriminating between patients at 30% and patients at 40% would be subjective. In the definition of terms for PPS (Appendix 1), authors of the scale indicate that patients rated at 30% are unable to get out of bed at all and unable to do any self-care, including eating without help, but clinicians may use only the table and not refer to the definitions when rating patients. Again, with scores of 50% and 60%, differentiation is based on ambulation, activity, and self-care. The differentiation between mainly sit-lie at 50% and reduced ambulation at 60% is ambiguous, as are the differences in activity (unable to do any work at 50% and unable to do hobby or housework at 60%) and self-care (considerable assistance in self-care at 50% and occasional assistance necessary at 60%). Patients may fluctuate related to any of these factors on a day to day basis, making it difficult for the rater to clearly rate the patient. Also, the assessing nurse may not always obtain full understanding of the patient's functional status during the assessment or first nursing visit.
Further investigation regarding this ambiguity in scoring between 50% and 60% revealed that many of the nurses at this particular hospice were unaware of the definition of terms used to discriminate among scores. We also found that nurses were scoring patients between levels, a practice discouraged by the creators of the tool. 21 These findings highlight the need for organizations using the tool to review the directions, criteria, and definitions with all users and assure that the tool is being used accordingly. A followup study at this hospice after in-servicing all the nurses on the instructions for use and definition of terms distributed with the scale might reveal better discrimination between categories.
Morita et al., 20 Virik and Glare, 19 and our study found distinct survival profiles based on the PPS scores. Unlike the Morita study, we did not have sufficient numbers of patients to substantiate individual categories for the 10% and Ն70% admission PPS categories. Notwithstanding, we found similarly distinct survival profiles, supportive of the assertion of the utility of admission PPS scores in predicting patient survival. Our results related to analysis by diagnosis groups are consistent with other studies evaluating noncancer diagnoses. We found noncancer diagnoses HEAD ET AL. 498 to be less predictable and that patients with lung disease and dementia have longer hospice stays on the average than patients with cancer. 7, 9, 23 While patients with dementia or debility had the lowest average PPS scores on admission and were the oldest of any patient group, 33.3% of them were discharged. The extreme differences between the mean and median lengths of survival for patients with lung disease and dementia may be reflective of the trajectory of these illnesses, with acute exacerbations and periods of stability, versus the gradual decline of the majority of patients with cancer. Patients discharged did not differ from patients who died based on the PPS at admission: the mean score for all patients was 38.9%, while the mean for discharged patients was 41.2%, and both groups had median scores of 40%. However, the scores of patients discharged did not decline significantly, as did the scores of patients who died. Stable PPS scores over time may well justify discharge, especially if the patient's length of stay approaches the outer limits of the 6-month Medicare benefit. Thus, it appears that stability in functional status over time may be predictive of an improved prognosis. Data related to survival patterns after being discharged alive were not available and, therefore, it was not possible to further assess the appropriateness of discharge decisions based on improved prognosis.
Certain characteristics of the study population limit analysis in this study. Heavy concentration of PPS scores in the 30% to 40% range, with very few cases having scores at either end of the scale, restricts comparative analysis. While we can determine the length of survival for patients in the range of from 30% to 40%, low numbers in the 10% to 20% and 70% and above ranges limit what we can predict for patients in these ranges. The overall short length of stay for hospice patients in the study hospice, a problem common to most hospice programs, means that the majority of the patients have low scores based on physical function.
The data set used for this study required PPS scoring by the same clinician who acted on the score (i.e., the nurse assigning the PPS score helped decide when and if the patient would be discharged). This is a limiting factor in evaluating the relationship of PPS scores to discharge decisions, as is the low number of patients discharged in this study population.
Another limiting factor was the low numbers of patients admitted with noncancer diagnoses. Our data support differences in functional performance and length of survival among the major hospice diagnoses groups, but results may be more generalizable if a greater number of noncancer patients had been included. However, we chose to define our population by admission date rather than diagnosis group.
CONCLUSIONS
In this study, the PPS proved to be significantly associated with hospice length of survival. Patterns of change in PPS scores over time can assist with decisions to discharge from hospice. As with any tool, it is important that all users receive ongoing instructions regarding its use, with a periodic review of rating criteria.
